Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.

Lonergan CL, McNamara EK, Cordoro KM, Greer KE.

Cutis. 2010 Apr;85(4):199-202.

PMID:
20486460
2.

Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.

Tillman DK Jr, Carroll MT.

Cutis. 2007 Mar;79(3):241-8.

PMID:
17674590
3.

Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.

Stockfleth E, Sterry W, Carey-Yard M, Bichel J.

Br J Dermatol. 2007 Dec;157 Suppl 2:41-6.

PMID:
18067631
4.

[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].

Oster-Schmidt C, Altmeyer P, Markus S.

J Dtsch Dermatol Ges. 2003 Oct;1(10):790-6. Review. German.

PMID:
16281815
5.

Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.

Boonchai W.

Arch Dermatol. 2006 Apr;142(4):531-2. No abstract available.

PMID:
16618886
6.

[Arsenical keratoses and carcinomas].

Fumal I, Piérard-Franchimont C, Piérard GE.

Rev Med Liege. 2005 Apr;60(4):217-21. French.

7.

Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.

Stockfleth E, Meyer T, Benninghoff B, Christophers E.

Br J Dermatol. 2001 May;144(5):1050-3.

PMID:
11359396
9.

Two cases of squamous cell carcinoma treated with topical imiquimod 5%.

Oster-Schmidt C.

J Eur Acad Dermatol Venereol. 2004 Jan;18(1):93-5.

PMID:
14678542
10.
11.

Topical imiquimod to treat intraepidermal carcinoma.

Hengge UR, Stark R.

Arch Dermatol. 2001 Jun;137(6):709-11. No abstract available.

PMID:
11405756
12.

Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.

Warshauer E, Warshauer BL.

J Drugs Dermatol. 2008 May;7(5):447-51.

PMID:
18505136
13.

Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.

Rigel DS, Torres AM, Ely H.

J Drugs Dermatol. 2008 Jan;7(1 Suppl 1):s15-6.

PMID:
18277458
14.

Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.

Weisberg NK, Varghese M.

Dermatol Surg. 2002 Jun;28(6):518-23.

PMID:
12081683
15.

Update on actinic keratosis in clinical trial experience with imiquimod.

Ferrándiz C.

Br J Dermatol. 2007 Dec;157 Suppl 2:32-3. Review.

PMID:
18067629
16.

Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.

Kocabaş E, Ermertcan AT, Bilaç C, Bilaç DB, Temiz P.

Cutan Ocul Toxicol. 2010 Dec;29(4):300-2. doi: 10.3109/15569527.2010.503177. Epub 2010 Aug 4.

PMID:
20684662
17.

Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.

Tiodorovic-Zivkovic D, Zalaudek I, Longo C, De Pace B, Albertini G, Argenziano G.

Eur J Dermatol. 2012 Jul-Aug;22(4):579-80. doi: 10.1684/ejd.2012.1771. No abstract available.

PMID:
22652500
18.

Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.

Dirschka T, Schmitz L, Bartha Á.

Eur J Dermatol. 2016 Aug 1;26(4):408-9. doi: 10.1684/ejd.2016.2788. No abstract available.

PMID:
27097553
19.

Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.

van Meurs T, van Doorn R, Kirtschig G.

Dermatol Surg. 2007 May;33(5):623-6; discussion 626-7. No abstract available.

PMID:
17451589
20.

Imiquimod - Its role in the treatment of cutaneous malignancies.

Bubna AK.

Indian J Pharmacol. 2015 Jul-Aug;47(4):354-9. doi: 10.4103/0253-7613.161249. Review.

Supplemental Content

Support Center